Why Has Gene Therapy for Hemophilia Been Slow to Catch On? After years of excitement about a possible “one-and-done” treatment, gene therapy uptake has been slower than expected. Here’s why. Read More Novel Technologies, Hemophilia A&B What Are Biosimilars? A Guide for People with Bleeding Disorders Similar to biologic medications, this type of therapy is safe and effective and could expand your access to treatment. Read More Hemophilia A&B, Novel Technologies OhmBody: A New Approach to Therapy for Heavy Menstrual Bleeding The wearable wellness device works without medications or hormones and complements other bleeding disorder treatments. Read More Women's Bleeding Disorders, Novel Technologies, Alternative Treatments What Is Anti-TFPI? This New Treatment Could Change Hemophilia Care This rebalancing agent can help people with hemophilia A or B — with or without inhibitors — to better control... Read More Hemophilia A&B, Novel Technologies Gene Therapy Candidates Face ‘Once in a Lifetime’ Choice You only get one chance. Cutting-edge gene therapies that show the most promise for a permanent solution to hemophilia rely... Read More Novel Technologies The Future of Digital Health Roshni Kulkarni, M.D., recalls a time when a patient was attacked by a wild turkey and wanted advice about whether... Read More Novel Technologies Telehealth for the Bleeding Disorders Community Remote work, remote learning, remote meetups with friends — Americans have gotten much more comfortable conducting critical (and noncritical) tasks... Read More Novel Technologies Gene Therapy and Bleeding Disorders: Where Are We Now, and What’s on the Horizon? Since 1966, leading immunologists, clinicians and researchers in gene therapy have been convening every one to three years to discuss... Read More Novel Technologies An Update on Gene Therapy for Hemophilia After several decades of research, gene therapy for hemophilia is moving closer to becoming a reality. One of the most... Read More Novel Technologies NIH State of the Science: A Look Back and a Way Forward On two rainy days in May 2018, more than 200 researchers, clinicians, pharmaceutical industry representatives, government officials, and patient advocates... Read More Researcher Profiles Judith Graham Pool Postdoctoral Research Fellow Sol Schulman, MD, PhD For Sol Schulman, MD, PhD, a principal investigator in the Division of Hemostasis and Thrombosis at Beth Israel Deaconess Medical... Read More Researcher Profiles Shared Decision-Making for Bleeding Disorders Brandon Downey, 32, a nurse in Chicago with severe hemophilia A, has switched treatments several times over the last decade... Read More Novel Technologies Load More
